Please try another search
Shedir Pharma Group S.p.A., through its subsidiaries, engages in the research, formulation, development, and marketing of nutraceuticals, dermocosmetics, medical devices, and pharmaceutical products in Italy. It provides products for andrological, cardiovascular, dermatological, hematological, energy, gastrointestinal, gynecological, metabolic, neurological, dental, ophthalmic, osteoarticular, otologic, respiratory, and trichological diseases. The company offers its products through a network of sales agents, wholesalers, and pharmacies. Shedir Pharma Group S.p.A. was founded in 2008 and is based in Naples, Italy.
Name | Age | Since | Title |
---|---|---|---|
Ignatius Pellecchia | 53 | - | Chairman of the Board of Statutory Auditors |
Umberto Di Maio | 50 | 2016 | Chairman of the Board |
Marco Mazzarese | 45 | 2019 | Independent Director |
Piermario Gargiulo | 50 | 2019 | Statutory Auditor |
Cristofaro Stinca | 55 | 2018 | Statutory Auditor |
Giuseppina Fusco | 47 | 2019 | Director |
Antonio Scala | 39 | 2019 | MD, CEO & Director |
Lucio Fusaro | 68 | - | Director |
Franco Raddi | 65 | - | President of the Board of Statutory Auditors |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review